# Calcium Bone Mineral Density Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/calcium-bone-mineral-density-randomized-trial-evidence-review
Category: evidence-review
Summary: Calcium Bone Mineral Density Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-06-08
Reviewed by: Migaku Evidence Review
# Calcium Bone Mineral Density Randomized Trial: What the Evidence Says

## Quick Answer

Calcium Bone Mineral Density Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Revisiting Intranasal Salmon Calcitonin: Historical Osteoporosis Evidence and a Potential Role in Acute Orthopaedic Pain Management | narrative review | 3 | 2026-04-01 | 10.2106/JBJS.RVW.26.00021 |
| The effects of dairy products containing Lactobacillus bulgaricus and Streptococcus thermophilus on bone turnover biomarkers and bone mineral density: a pilot trial study | research article | 4 | 2026-03-05 | 10.3389/fnut.2026.1785177 |

## What The Sources Report

- Accordingly, contemporary guidelines no longer recommend IN-CAL as first-line treatment for chronic osteoporosis, and concerns regarding a potential malignancy signal further limited long-term use. [Ahmad Areeb (2026); evidence level 3]
- A landmark review by Plosker and McTavish summarized the pharmacologic and clinical evidence for IN-CAL through the mid-1990s. [Ahmad Areeb (2026); evidence level 3]
- Low BMD substantially impairs quality of life, as it is commonly associated with chronic pain, reduced mobility, and an increased risk of fractures. [Rueangsri Narisa (2026); evidence level 4]
- In Thailand, the prevalence of bone fragility and osteoporosis has steadily increased, largely due to population aging and persistently insufficient calcium intake. [Rueangsri Narisa (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For calcium bone mineral density randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Ahmad Areeb (2026). Revisiting Intranasal Salmon Calcitonin: Historical Osteoporosis Evidence and a Potential Role in Acute Orthopaedic Pain Management. DOI: 10.2106/JBJS.RVW.26.00021. PMCID: PMC13048325. PMID: 41945663. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-Non Commercial-No Derivatives License.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13048325/
- Rueangsri Narisa (2026). The effects of dairy products containing Lactobacillus bulgaricus and Streptococcus thermophilus on bone turnover biomarkers and bone mineral density: a pilot trial study. DOI: 10.3389/fnut.2026.1785177. PMCID: PMC12999405. PMID: 41867674. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12999405/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.